Atlas Trials

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

Clinical trial NCT01424566 · COMPLETED

Trial details

NCT number
NCT01424566
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
PainAdvanced Cancer
Start date
2012-06-29
Primary completion
2015-07-10
Enrollment
406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.